Biochemical Pathophysiology & MNT Objectives
In CKD Stages 3–4 (eGFR 15–59 mL/min/1.73m²), progressive nephron loss leads to impaired nitrogenous waste elimination, secondary hyperparathyroidism via phosphate retention and calcitriol deficiency, and metabolic acidosis. Excess dietary protein exacerbates intraglomerular hypertension and hyperfiltration, accelerating renal functional decline.
Syntro Health strictly adheres to KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guidelines. Our deterministic engine calculates exact daily protein gram ceilings, isolates hidden inorganic phosphorus food additives, and filters potassium content with food preparation protocols (such as vegetable leaching techniques) to safeguard renal parenchyma.
Daily Macronutrient & Micronutrient Targets
Calibrated against ICMR-NIN 2020 RDA tables and international condition consensus standards:
| Nutrient | Clinical Target | Physiological Rationale |
|---|---|---|
| Protein Ceiling | 0.6–0.8 g/kg dry weight | ≥50% High Biological Value (HBV) protein to satisfy essential amino acid minimums. |
| Energy Density | 30–35 kcal/kg/day | Crucial to prevent catabolic protein breakdown into nitrogenous waste. |
| Phosphorus Floor | <800 mg/day | Organic plant phosphate prioritized; absolute exclusion of inorganic phosphate preservatives. |
| Potassium Threshold | 1,500–2,000 mg/day (if eGFR <30) | Adjusted dynamically based on serum K+ and RAAS inhibitor pharmacology. |
| Sodium Restriction | <1,500–2,000 mg/day | Strict avoidance of potassium chloride "light" salt substitutes due to lethal arrhythmia risk. |
Therapeutic Food Matrix: Foods to Prioritize vs. Avoid
Foods to Include
Pure albumin with near-zero phosphorus content; ideal for satisfying EAA needs without nitrogen burden.
Mild vegetable with negligible potassium and phosphorus; easily leached to further drop electrolyte density.
Significantly lower in inorganic phosphorus and potassium compared to whole wheat or brown rice; safe energy base.
Safe fruit options providing dietary fiber and bioflavonoids without spiking serum potassium levels.
High-protein source when prepared from boiled curdled milk with drained whey to minimize potassium.
Foods to Restrict
Contains caramboxin and oxalate; patients with renal clearance impairment experience intractable hiccups, seizures, and fatal encephalopathy.
Replaces sodium with potassium chloride; rapid serum potassium elevation triggers cardiac arrest.
Inorganic phosphate additives have ~100% intestinal absorption efficiency, worsening vascular calcification.
Extreme potassium load (>500mg/100g) risks hyperkalemia and renal oxalate crystal deposition.
Dense concentration of organic phytic phosphorus exceeds daily renal excretion capacity.
Pharmacological & Drug-Nutrient Safeguards
Syntro Health checks 30+ deterministic pharmacology rules before delivering your meal plan:
Aldosterone suppression reduces renal potassium excretion. Syntro enforces <2,000mg dietary potassium cap.
Must be taken with the first bite of meals containing phosphorus. Cannot be taken on an empty stomach.
Monitors systemic sodium intake to balance metabolic acidosis correction against fluid overload.
How Syntro Health Builds Your Chronic Kidney Disease (Stages 3–4 Non-Dialysis) Protocol
Stage & eGFR Stratification
Syntro checks your serum creatinine, eGFR, and urine albumin-to-creatinine ratio (uACR) to assign precise CKD stage.
Nitrogenous Protein Cap Calculation
Calculates the 0.6–0.8 g/kg dry weight protein ceiling to prevent uremic toxin synthesis.
Electrolyte & Additive Filtering
Screens all ingredient matrices for potassium, phosphorus preservatives, and high sodium content.
Leaching Technique Instructions
Applies culinary preparation protocols (cutting, soaking in warm water for 2 hours, boiling, draining) to lower vegetable potassium.
Mandatory Clinical Safety Audit
Screens against stage 5 or dialysis status; enforces hard referral gate for end-stage renal disease.
Frequently Asked Questions
Clinical Evidence & Guidelines Referenced
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease — Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2024;105(4S):S117-S314. Source link
- KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update — Ikizler TA, et al.. Am J Kidney Dis 2020;76(3 Suppl 1):S1-S107. Source link
- Protein-restricted diets in CKD: update and clinical consensus — Kalantar-Zadeh K, Fouque D. N Engl J Med 2017;377:1765-1776. Source link